Showing results (361-370 of 4,241) with videos related to

Sort By:
Pageof 425
Journal for Immunotherapy of Cancer|July 1, 2025
Enhanced antitumor immunity of VNP20009-CCL2-CXCL9 via the cGAS/STING axis in osteosarcoma lung metastasisRuixuan Liu, Qi Liu, Yuming Wang, et al.
Journal for Immunotherapy of Cancer|June 24, 2025
Systematic identification and targeting of master regulator checkpoints (MRC) governing tumor microenvironment-mediated immune evasionPasquale Laise, Gideon Bosker, Mariana Babor, et al.
Journal for Immunotherapy of Cancer|January 12, 2026
Cell therapy in sarcoma: current landscape and future directionsTaha Koray Sahin, Theodora Germetaki, Deniz Can Guven, et al.
Journal for Immunotherapy of Cancer|December 25, 2025
AstroID resource: a scalable, relational database structure for longitudinal biomarker discoveryElizabeth M Will, Benjamin F Green, Scott Carey, et al.
Journal for Immunotherapy of Cancer|December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Journal for Immunotherapy of Cancer|January 6, 2026
Intratumoral dendritic cell immunotherapy controls dissemination of metastasis-initiating cancer cells, even in patients with metastatic breast cancerAixa Soyano, Marie Catherine Lee, Hyo S Han, et al.
Journal for Immunotherapy of Cancer|February 4, 2026
Tumor immune microenvironment facilitates resistance to KRAS G12C inhibitor sotorasib by altered PD-L1 expressionShougeng Liu, Yiting Jiang, Yudong Fu, et al.
Journal for Immunotherapy of Cancer|December 25, 2025
Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanomaMelissa M Yamada, Smitha Chandrasekhar, Ted A Gooley, et al.
Journal for Immunotherapy of Cancer|December 30, 2025
Overcoming impaired antigen presentation in tumor-draining lymph nodes facilitates immunotherapyMeghan J O'Melia, Lutz Menzel, Pin-Ji Lei, et al.
Pageof 425